Rein Therapeutics, Inc. (RNTX)
0.791
-0.01
(-1.12%)
USD |
NASDAQ |
Sep 21, 16:00
0.791
0.00 (0.00%)
After-Hours: 20:00
Rein Therapeutics Market Cap : 67.84M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 68.61M |
| September 17, 2026 | 67.69M |
| September 16, 2026 | 60.22M |
| September 15, 2026 | 60.68M |
| September 14, 2026 | 67.84M |
| September 11, 2026 | 67.33M |
| September 10, 2026 | 66.98M |
| September 09, 2026 | 70.97M |
| September 08, 2026 | 73.97M |
| September 04, 2026 | 76.26M |
| September 03, 2026 | 72.35M |
| September 02, 2026 | 66.45M |
| September 01, 2026 | 64.56M |
| August 31, 2026 | 64.32M |
| August 28, 2026 | 65.36M |
| August 27, 2026 | 67.14M |
| August 26, 2026 | 68.61M |
| August 25, 2026 | 68.61M |
| August 24, 2026 | 68.61M |
| August 21, 2026 | 70.16M |
| August 20, 2026 | 68.06M |
| August 19, 2026 | 67.93M |
| August 18, 2026 | 66.05M |
| August 17, 2026 | 72.16M |
| August 14, 2026 | 69.13M |
| Date | Value |
|---|---|
| August 13, 2026 | 67.54M |
| August 12, 2026 | 69.04M |
| August 11, 2026 | 70.06M |
| August 10, 2026 | 22.26M |
| August 07, 2026 | 22.92M |
| August 06, 2026 | 22.11M |
| August 05, 2026 | 20.03M |
| August 04, 2026 | 21.41M |
| August 03, 2026 | 20.90M |
| July 31, 2026 | 20.68M |
| July 30, 2026 | 21.53M |
| July 29, 2026 | 21.25M |
| July 28, 2026 | 21.92M |
| July 27, 2026 | 21.92M |
| July 24, 2026 | 22.19M |
| July 23, 2026 | 22.43M |
| July 22, 2026 | 23.55M |
| July 21, 2026 | 25.09M |
| July 20, 2026 | 23.66M |
| July 17, 2026 | 24.17M |
| July 16, 2026 | 24.17M |
| July 15, 2026 | 26.53M |
| July 14, 2026 | 25.68M |
| July 13, 2026 | 25.45M |
| July 10, 2026 | 27.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.66B |
| Anika Therapeutics, Inc. | 277.30M |
| Savara, Inc. | 1.120B |
| Vericel Corp. | 2.023B |
Market Cap Related Metrics
| Price to Book Value | 6.652 |
| Price | 0.791 |
| Earnings Yield | -217.2% |